Register entry

PLD Acquisitions LLC DBA Avma Pharma Solutions

Data as of · How to read this entry

Registered sites
0
Active NDC listings
27
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

27

27 active NDC listings: 14 human otc drug, 11 bulk ingredient, 2 human prescription drug. By marketing category: ANDA 15, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 11, DRUG FOR FURTHER PROCESSING 1.

Dosage formNDCs
tablet, delayed release8
tablet6
tablet, coated4
tablet, film coated4
lozenge2
solution2
capsule1
RouteNDCs
oral15
Labeller name on the listingNDCs
pld acquisitions llc dba avma pharma solutions27
Catalogue

Marketed products

27
BrandGeneric nameForm / routeNDC
Allergy ReliefFexofenadine HCltablet, coated, oral63548-0663ANDA
Allergy ReliefFexofenadine HCltablet, oral63548-0664ANDA
-Aspirintablet63548-0867DRUG FOR FURTHER PROCESSING
-Calcium Acetatecapsule63548-6990BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Childrens Allergy ReliefFexofenadine HCLtablet, oral63548-0662ANDA
IbuprofenIbuprofentablet, coated, oral63548-0185ANDA
IbuprofenIbuprofentablet, coated, oral63548-0234ANDA
Ibuprofen 200 mg and Diphenhydramine Citrate 38 mgIbuprofen, Diphenhydramine Citratetablet, oral63548-0197ANDA
-Ibuprofen Diphenhydramine Citratetablet, coated63548-1970BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
LoratadineLoratadinetablet, oral63548-0753ANDA
-Loratadinetablet63548-9150BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Nicotine Mininicotine polacrilexlozenge, oral63548-0262ANDA
Nicotine Mininicotine polacrilexlozenge, oral63548-0264ANDA
OmeprazoleOmeprazoletablet, delayed release, oral63548-2970ANDA
-Omeprazoletablet, delayed release63548-2971BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
OmeprazoleOmeprazoletablet, delayed release, oral63548-4080ANDA
OmeprazoleOmeprazoletablet, delayed release, oral63548-7370ANDA
OmeprazoleOmeprazoletablet, delayed release, oral63548-8040ANDA
-Omeprazole Magnesiumtablet, delayed release63548-7371BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Prednisolone Sodium Phosphatesolution63548-5300BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Prednisolone Sodium Phosphatesolution63548-5320BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Prilosec Omeprazoletablet, delayed release63548-9721BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Prilosec Omeprazoletablet, delayed release63548-9731BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
ZolmitriptanZolmitriptantablet, film coated, oral63548-0101ANDA
ZolmitriptanZolmitriptantablet, film coated, oral63548-0102ANDA
-Zolmitriptantablet, film coated63548-1010BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Zolmitriptantablet, film coated63548-1020BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Compare

Other companies listing omeprazole

Enquiry

Common questions

Is PLD Acquisitions LLC DBA Avma Pharma Solutions FDA approved?
PLD Acquisitions LLC DBA Avma Pharma Solutions holds no registered establishment of its own; 27 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does PLD Acquisitions LLC DBA Avma Pharma Solutions make?
27 products are listed under PLD Acquisitions LLC DBA Avma Pharma Solutions in the openFDA NDC Directory, most often as tablet, delayed release; tablet; tablet, coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.